CE Luncheon: The Opioid Epidemic

Constellation Behavioral Health
Clinical Professional CE Luncheon

The Opioid Epidemic:
Current Trends and Best Medical Practices

Thursday, April 20th
11:30am – 1:30pm

Capital Club Silicon Valley
50 W. San Fernando St. | San Jose, CA 95113

Join Constellation Behavioral Health on Thursday, April 20th as we take a closer look into the opioid epidemic with Suma Singh, M.D.  Dr. Singh will discuss elements of the epidemic, and introduce a medication assisted treatment option called ER-Naltrexone (Vivitrol) to treat opiate dependence.

Lunch and refreshments will be provided.
As space is limited, a RSVP is required for this event.

Agenda

11:30am – 12:00pm:  Registration & Networking
(No CEs/CEUs provided for this portion)

12:00pm – 1:00PM: Presentation by Suma Singh, M.D.
1 APA CE hour or 1 CAMFT CEU

1:00pm – 1:30pm: Q&A, Sign-out, and networking
(No CEs/CEUs provided for this portion)

There is no cost for this event.

If all criteria is met, participant will receive a course completion certificate via email within seven (7) days of completing the course.

Please contact Julia Babcock at jbabcock@constellationbh.com or 415-275-7229 at least 24 hours prior to the event if you need to cancel your seat.

There is no commercial support provided for this program.


Suma Singh Presentation

Presenter: Suma Singh, M.D.

With more than 20 years of experience in Addiction Medicine, Dr. Singh has cared for thousands of patients with addiction, and developed novel therapeutics as a clinical researcher to reduce the abuse potential of opiates.  She is a member of the California Public Health Task Force on Prescription Overdose Epidemic, and Santa Clara County Task Force for Opioid Overdose Prevention.  She is also a member of California Society of Addiction Medicine and American Society of Addiction Medicine.  Dr. Singh is Board Certified in Addiction Medicine, and holds degrees from Stanford University Medical School, Harvard Medical School, and Boston University School of Medicine.  She also has a lifelong passion for ancient traditions of health and wellness (ayurveda), vegetarianism and non-violence.

Presentation Abstract:
This presentation will discuss elements of the opioid epidemic, and introduce a medication assisted treatment option called ER-Naltrexone (Vivitrol) to treat opiate dependence.


APA Continuing Education Credit Information

Constellation Behavioral Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Constellation Behavioral Health maintains responsibility for this program and its content. 

Educational Objectives

Participants will be able to:
1. Identify the scope and depth of the opioid epidemic nationally and locally
2. Identify at least two (2) relevant social trends contributing to the opioid epidemic
3. Identify at least one (1) NIDA opioid overdose prevention measure to use in one’s clinical practice

Audience Level: Introductory

1 APA CE Credit will be provided for this presentation. (All participant criteria must be met to earn the credit).

All CE event venues are toured by CE Administration prior to approval for sponsoring a CE event, to ensure all ADA standards are met. If you have concerns, questions, or special needs requests for ADA accommodations, contact: Ms. Christi Cessna, M.S., CE Administrator, 591 Redwood Highway, Suite 5220, Mill Valley, California 94941 / Telephone: 415-275-7229 


CAMFT Continuing Education Credit Information

Constellation Behavioral Health (Approval #: 134068)  is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for Licensed Marriage and Family Therapists, Licensed Clinical Social Worker, Licensed Professionals Clinical Counselor, and Licensed Educational Psychologists. Constellation Behavioral Health (Approval #: 134068)   maintains responsibility for this program and its content.

Educational Goals

Participants will be able to:
1. Identify the scope and depth of the opioid epidemic nationally and locally.
2. Apply knowledge of opioid overdose prevention measures.
3. Understand the safety and efficacy of naltrexone to enhance treatment outcomes for your clients.

Learning Objectives

Participants will be able to:
1. Identify at least two (2) relevant social trends contributing to the opioid epidemic.
2. Identify at least one (1) NIDA opioid overdose prevention measure to use in one’s clinical practice.

Target Audience: LMFTs, LCSWs, and LPCCs, Introductory Level

This course meets the qualifications for 1 hour of continuing education credit for LMFTs, LCSWs, and LPCCs as required by the California Board of Behavioral Sciences.

If you have questions or concerns contact: Ms. Christi Cessna, M.S., CE Administrator, 591 Redwood Highway, Suite 5220, Mill Valley, California 94941

All CE event venues are toured by CE Administration prior to approval for sponsoring a CE event, to ensure all ADA standards are met. Please call Christi Cessna, Program Administrator, to request special needs accommodations at 415-275-7220.